Medco Finance Limited Review
39
Review
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | July 2025 | 0 |
| August 2025 | 0 | |
| September 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About Medco Finance Limited
Medco Finance Limited operates under the website medcofinance.com (and variants like medcofinance.vip) and claims a U.S. base at Sweetwood Drive Street, Boulder, Colorado 80302, United States, with contact details including telephone +44 2080895770 and email info@medcofin.com ().
The UK’s Financial Conduct Authority (FCA) issued an official warning on 3 March 2023, declaring that Medco Finance Limited is an unauthorised firm and a clone of a UK‑registered company, operating without FCA authorisation; the firm is not listed on the FCA register, and users will not benefit from the Financial Ombudsman Service or the Financial Services Compensation Scheme (). The FCA further lists the firm as “unauthorised” in its warning list with the same address and contact details ().
No regulation or license has been identified from any Tier‑1 regulator (such as FCA, CySEC, ASIC, CFTC/NFA). The firm does not appear in the NFA register despite its U.S. address, and no licensing information is disclosed on its site or official documents ().
Trading conditions, as described by third‑party reviews (not from the broker itself), mention a minimum deposit of €100, leverage up to 1:200, a web‑based platform (not MetaTrader), and five account types: Beginner, Silver, Investor, Premium, Gold (). These reviews also highlight contradictory or incomplete information, nonexistent deposit/withdrawal menus, and advertised bonuses—all red flags absent transparency ().
Who it’s for
- Not applicable—no factual basis to define a legitimate target audience due to lack of regulation, transparency, and evidence of actual operations.
Pros and cons
Pros
- No verified factual evidence supports any operational or legitimacy strengths.
Cons
- Firm is unauthorised and marked as a clone by the FCA; operates without regulatory oversight ().
- No licences or regulatory affiliation with any major financial authority (FCA, NFA/CFTC, ASIC, CySEC) ().
- Trading conditions and platform claims are inconsistent and unsupported by verifiable evidence ().
